Abstract:Background Advanced hepatocellular carcinoma (HCC) patients undergo significant tumor growth and metastasis. Here, we investigated bufalin for treating HCC, which exhibits anti-tumor activities in many tumor cell lines. Method In our experiment, HCCLM3-R cells were injected into nude mice to form subcutaneous human HCC tumors that were implanted into the liver to establish orthotopic transplantation tumor models. Bufalin was injected intraperitoneally at 1 or 1.5 mg/kg. LY294002 (100 mg/kg), a potent inhibitor of Akt which reduced the levels of pAkt in HCCLM3 cell lines, was injected intraperitoneally into one group thrice weekly. The control was injected with an equal volume of saline. Morphological alterations were evaluated in the liver and lung by stereomicroscopy, the apoptotic rate was measured by TUNEL staining, and expression of AKT/GSK3β/β-catenin/E-cadherin signaling pathway-related proteins was detected by immunohistochemistry (IHC) and western blot analysis. Results These results suggested that the sizes and qualities of orthotopic transplanted tumors as well as pulmonary metastasis decreased markedly at the highest bufalin dose compared with that in the control. Orthotopic transplanted tumor tissues were necrotic in bufalin-treated groups and the apoptotic cell number was markedly higher at the highest bufalin dose compared with that in the control. Certain changes of expression of AKT/GSK3β/β-catenin/E-cadherin signaling pathway-related proteins were in tumor tissues, which were related to the bufalin dose. Similar results were observed in the LY294002-treated group. Conclusion Based on the above, one can draw conclusions that bufalin has significant anti-tumor activities and reduces the metastatic potential in an orthotopic transplantation tumor model of human HCC. Inhibition of AKT/GSK3β/β-catenin/E-cadherin signaling pathways by bufalin may show therapeutic effects in advanced HCC patients.

Bufalin‐inhibited Migration and Invasion in Human Osteosarcoma U‐2 OS Cells is Carried out by Suppression of the Matrix Metalloproteinase‐2, ERK, and JNK Signaling Pathways

Bufalin Induces Apoptosis of Human Osteosarcoma U-2 OS Cells Through Endoplasmic Reticulum Stress, Caspase- and Mitochondria-Dependent Signaling Pathways

Bufalin Inhibits Migration and Invasion in Human Hepatocellular Carcinoma SK-Hep1 Cells Through the Inhibitions of NF-kB and Matrix Metalloproteinase-2/-9-signaling Pathways.

Bufalin Inhibits Htert Expression and Colorectal Cancer Cell Growth by Targeting CPSF4

Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221

Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis in Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.

Bufalin induces apoptosis in the U‑2OS human osteosarcoma cell line via triggering the mitochondrial pathway.

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Inhibition Effect of Bufalin on Invasion and Metastasis of Gastric Cancer Cells

Bufalin Inhibits Gefitinib Resistant NCI-H460 Human Lung Cancer Cell Migration and Invasion in Vitro.

Experiment of bufalin on chemosensitivity to human osteosarcoma cells in vitro

Bufalin induces apoptosis and autophagy via the Ca2+/CaMKKβ/AMPK/Beclin1 signaling pathway in osteosarcoma cells

Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.

Bufalin Suppresses Hepatocellular Carcinoma Invasion and Metastasis by Targeting HIF-1α Via the PI3K/AKT/mTOR Pathway.

Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model Through Genes Related to Apoptotic and PTEN/AKT Pathways

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice

Bufalin Induces G0/G1 Phase Arrest Through Inhibiting the Levels of Cyclin D, Cyclin E, CDK2 and CDK4, and Triggers Apoptosis Via Mitochondrial Signaling Pathway in T24 Human Bladder Cancer Cells

Bufalin Inhibits Tgf-Beta-Induced Epithelial-To-Mesenchymal Transition And Migration In Human Lung Cancer A549 Cells By Downregulating Tgf-Beta Receptors

Bufalin Suppresses the Migration and Invasion of Prostate Cancer Cells Through HOTAIR, the Sponge of Mir-520B

Bufalin, a Traditional Chinese Medicine Compound, Prevents Tumor Formation in Two Murine Models of Colorectal Cancer

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells